SEC filing · 8-K

PMV Pharmaceuticals, Inc.: Executive or director change

PMV Pharmaceuticals appointed Dr. Matthew Eckler to its Board of Directors.

Filed October 5, 2026

Positive for the company

What happened

On October 1, 2026, Dr. Matthew Eckler joined the Board of Directors with a term expiring at the 2029 Annual Meeting of Stockholders.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to PMV Pharmaceuticals, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.